CLINICAL_TRIALS
withdrawal
· 2015-04-09
Clinical Trial Update: Study of Varencline Effects on Cigarette Smoking Reward and Craving During a Model of Brief Quit Attempt [Phase 1, Phase 2]
Summary
The Phase 1/2 trial investigating varenicline effects on cigarette smoking reward and craving during a brief quit attempt has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NYU Langone Health | Conditions: Nicotine Dependence | Phase 1, Phase 2 | Status: WITHDRAWN